Company intelligence / Profile preview

BioTalentum

Ownership: Private
Employees: ~11
Development stage: Preclinical

Overview

BioTalentum develops advanced human stem cell-based systems and transgenic animal models to support biomedical research, in vitro toxicology, drug discovery, and regenerative medicine. Their platforms are used by academic groups as well as pharmaceutical/biotech companies worldwide to accelerate preclinical research. No direct clinical results as they do not develop therapeutics themselves.

Therapeutic areas: Other
Modalities: Induced pluripotent stem cell derived therapyStem cell therapyGene editing (as a service/tool)Recombinant protein (for in vitro models)Cell therapy (general)Animal model development (transgenic models)
Industry: Non-Drug Biotech

Partnerships

Numerous EU-funded consortia/projects including HORIZON RIA EMBRACEEIC Pathfinder SynmechERASMUS LS BrightSkillsMSCA Doctoral Networks MMM/TClock4AD/Chrom_Rare/NOVEL etc.COST actions BenBedPhar/HAPLO-iPS/IMMUPARKNET/GenE-Humdi/EPI3E/NDCil

Beyond the preview

Go deeper on BioTalentum.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioTalentum.

Explore the full profile